A Study of the Effect of BIIB023 on Muscle Atrophy in Healthy Male Volunteers
Completed · Phase 1 · Has a placebo group
Conditions studied: Healthy
In brief
The primary objective of this study is to determine whether muscle atrophy induced by immobilization of the lower limb can be attenuated by BIIB023 in healthy male volunteers. The secondary objectives of this study in this study population are: * To determine whether muscle weakness induced by immobilization of the lower limb can be attenuated by BIIB023 * To assess the effect of BIIB023 on the recovery of muscle mass and strength after immobilization * To assess the effect of BIIB023 on histological markers of muscle atrophy and regeneration * To assess the effect of BIIB023 on muscle bioenergetics based on oxidative metabolism recovery kinetics * To evaluate the safety and tolerability of BIIB023
Key facts
- Study ID
- NCT01943513
- Run by
- Biogen
- People needed
- 34
- Starts
- 2013-10-01
- Expected to finish
- 2014-05-01
- Last updated by the study team
- 2014-09-03
Who can join
Age: 18 and older, up to 35. Sex: male. Healthy volunteers: accepted.
Where it is running
- Research Site — Evansville, Indiana, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.